A "what will impact the sector going forward" kind of thread. We're not a "rah-rah, go biotech" forum, and critical commentary concerning valuations is frequent. We **will** discuss BVF/Lampert and other funds/fund managers which/who have distinct styles and which/who impact the sector. It is not a forum for company-specific discussion, unless it involves someone with deep pockets, stumbling around in such an obvious fashion that no-brainer opportunities are created.